Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma.

M Junaid HussainMyra M RobinsonIssam HamadehJustin ArnallManisha BhutaniShebli AtrashReed FriendMauricio Pineda-RomanJames T SymanowskiSaad Z UsmaniPeter M Voorhees

Published in: British journal of haematology (2018)

Keyphrases

multiple myeloma
combination therapy
low dose
high dose